Zi‐Ning Lei

Dacomitinib antagonizes multidrug resistance (MDR) in cancer cells by inhibiting the efflux activity of ABCB1 and ABCG2 transporters

Yingfang Fan, Wei Zhang, Leli Zeng et al. · Cancer Letters · 2018 · 111 citations · Full text

Multidrug Resistance, Cancer Biology, Abcg2 Transporters +18

Selonsertib (GS-4997), an ASK1 inhibitor, antagonizes multidrug resistance in ABCB1- and ABCG2-overexpressing cancer cells

Ning Ji, Yuqi Yang, Chao‐Yun Cai et al. · Cancer Letters · 2018 · 105 citations · Full text

Abcg2-overexpressing Cancer Cells, Oncology, Medicine +9

VS-4718 Antagonizes Multidrug Resistance in ABCB1- and ABCG2-Overexpressing Cancer Cells by Inhibiting the Efflux Function of ABC Transporters

Ning Ji, Yuqi Yang, Chao‐Yun Cai et al. · Frontiers in Pharmacology · 2018 · 72 citations · Full text

Abc Transporters, Atpase Analysis, Cancer Biology +18

Discovery of 5-Cyano-6-phenylpyrimidin Derivatives Containing an Acylurea Moiety as Orally Bioavailable Reversal Agents against P-Glycoprotein-Mediated Mutidrug Resistance

Bo Wang, Liying Ma, Jing‐Quan Wang et al. · Journal of Medicinal Chemistry · 2018 · 70 citations · Full text

Pharmaceutical Science, P-glycoprotein-mediated Mutidrug Resistance, Pharmacotherapy +16

Tepotinib reverses ABCB1-mediated multidrug resistance in cancer cells

Zhuo‐Xun Wu, Qiu‐Xu Teng, Chao‐Yun Cai et al. · Biochemical Pharmacology · 2019 · 68 citations

Tumor Biology, Medicine, Pharmacology +6